2,145
Views
1
CrossRef citations to date
0
Altmetric
Rotavirus – Research Paper

Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era

, , ORCID Icon, , , , , , & show all
Article: 2037983 | Received 02 Dec 2021, Accepted 01 Feb 2022, Published online: 03 Mar 2022

References

  • Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(2):136–7. doi:10.1016/S1473-3099(11)70253-5.
  • Matthijnssens J, Joelsson DB, Warakomski DJ, Zhou T, Mathis PK, van Maanen MH, Ranheim TS, Ciarlet M. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq®. Virology. 2010;403(2):111–27. doi:10.1016/j.virol.2010.04.004.
  • Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58:1–25.
  • Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa052434.
  • Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a eentavalent Human–Bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa052664.
  • Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, et al. Continued evidence of the impact of rotavirus vaccine in children less than 3 years of age from the United States new vaccine surveillance network: a multisite active surveillance program, 2006-2016. Clin Infect Dis. 2020;71(9):e421–e429. doi:10.1093/cid/ciaa150.
  • Hungerford D, Allen DJ, Nawaz S, Collins S, Ladhani S, Vivancos R, Iturriza-Gómara M. Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to August 2016. Euro Surveill. 2019;24(6):1700774. doi:10.2807/1560-7917.ES.2019.24.6.1700774.
  • Roczo-Farkas S, Kirkwood CD, Cowley D, Barnes GL, Bishop RF, Bogdanovic-Sakran N, Boniface K, Donato CM, Bines JE. The impact of rotavirus vaccines on genotype diversity: a comprehensive analysis of 2 decades of Australian surveillance data. J Infect Dis. 2018;218(4):546–54. doi:10.1093/infdis/jiy197.
  • Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009;4(10):1303–16. doi:10.2217/fmb.09.96.
  • Oishi T, Matsunaga M, Nakano T, Sudo S, Kuwajima H, Tokuriki S, Study SR. Letter from the editor. Hum Vaccin Immunother. 2020;16(1):1–7. doi:10.1080/21645515.2020.1704580.
  • Kobayashi M, Miyazaki M, Ogawa A, Tatsumi M. Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan. Hum Vaccin Immunother. 2020;16(1):132–37. doi:10.1080/21645515.2019.1638204.
  • Yoshikawa T, Matsuki T, Sato K, Mizuno M, Shibata M, Hasegawa S, Morita M, Iwasa M, Gopala K, Holl K. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan. Vaccine. 2018;36:527–34. doi:10.1016/j.vaccine.2017.12.006.
  • Asada K, Kamiya H, Suga S, Nagao M, Ichimi R, Fujisawa T, Umemoto M, Tanaka T, Ito H, Tanaka S, et al. Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan. Western Pac Surveill Response J. 2016;7(4):28–36. doi:10.5365/wpsar.2016.7.3.005.
  • Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22:259–67.
  • Miura H, Kawamura Y, Sugata K, Koshiyama N, Yoshikawa A, Komoto S, Taniguchi K, Ihira M, Yoshikawa T. Rotavirus vaccine strain transmission by vaccinated infants in the foster home. J Med Virol. 2017;89(1):79–84. doi:10.1002/jmv.24613.
  • Wu H, Taniguchi K, Wakasugi F, Ukae S, Chiba S, Ohseto M, Hasegawa A, Urasawa T, Urasawa S. Survey on the distribution of the gene 4 alleles of human rotaviruses by polymerase chain reaction. Epidemiol Infect. 1994;112(3):615–22. doi:10.1017/S0950268800051311.
  • Taniguchi K, Wakasugi F, Pongsuwanna Y, Urasawa T, Ukae S, Chiba S, Urasawa S. Identification of human and bovine rotavirus serotypes by polymerase chain reaction. Epidemiol Infect. 1992;109(2):303–12. doi:10.1017/S0950268800050263.
  • Cunliffe NA, Woods PA, Leite JP, Das BK, Ramachandran M, Bhan MK, Hart CA, Glass RI, Gentsch JR. Sequence analysis of NSP4 gene of human rotavirus allows classification into two main genetic groups. J Med Virol. 1997;53(1):41–50. doi:10.1002/(SICI)1096-9071(199709)53:1<41:AID-JMV8>3.0.CO;2-Q.
  • Maes P, Matthijnssens J, Rahman M, Van Ranst M. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol. 2009;9(1):238. doi:10.1186/1471-2180-9-238.
  • Hoque SA, Kobayashi M, Takanashi S, Anwar KS, Watanabe T, Khamrin P, Okitsu S, Hayakawa S, Ushijima H. Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan. Vaccine. 2018;36:43–49. doi:10.1016/j.vaccine.2017.11.056.
  • Maguire JE, Glasgow K, Glass K, Roczo-Farkas S, Bines JE, Sheppeard V, Macartney K, Quinn HE. Rotavirus epidemiology and monovalent rotavirus vaccine effectiveness in Australia: 2010-2017. Pediatrics. 2019;144(4):144. doi:10.1542/peds.2019-1024.
  • Carvalho-Costa FA, de Assis RMS, Fialho AM, Araújo IT, Silva MF, Gómez MM, Andrade JS, Rose TL, Fumian TM, Volotão EM, et al. The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®. BMC Pediatr. 2019;19(1):42. doi:10.1186/s12887-019-1415-9.
  • Thongprachum A, Khamrin P, Maneekarn N, Hayakawa S, Ushijima H. Epidemiology of gastroenteritis viruses in Japan: prevalence, seasonality, and outbreak. J Med Virol. 2016;88(4):551–70. doi:10.1002/jmv.24387.
  • de Oliveira LH, Camacho LA, Coutinho ES, Ruiz-Matus C, Leite JP. Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis. Vaccine. 2015;33(Suppl 1):A248–54. doi:10.1016/j.vaccine.2014.11.060.
  • Linhares AC, Velázquez FR, Pérez-Schael I, Sáez-Llorens X, Abate H, Espinoza F, López P, MacíMacíAs-Parra M, Ortega-BarríBarríA E, Rivera-Medina DM, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371(9619):1181–89. doi:10.1016/S0140-6736(08)60524-3.
  • Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370(9601):1757–63. doi:10.1016/S0140-6736(07)61744-9.
  • Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australiaʻs National Childhood vaccine schedule. Pediatr Infect Dis J. 2011;30(1):S25–9. doi:10.1097/INF.0b013e3181fefdee.
  • Haque W, Haque J, Barai D, Rahman S, Moni S, Hossain ME, Faruque ASG, Ahmed S, Zaman K, Rahman M. Distribution of rotavirus genotypes in Dhaka, Bangladesh, 2012–2016: re-emergence of G3P[8] after over a decade of interval. Vaccine. 2018;36(43):6393–400. doi:10.1016/j.vaccine.2018.08.081.
  • Guntapong R, Tacharoenmuang R, Singchai P, Upachai S, Sutthiwarakom K, Komoto S, Tsuji T, Tharmaphornpilas P, Yoshikawa T, Sangkitporn S, et al. Predominant prevalence of human rotaviruses with the G1P[8] and G8P[8] genotypes with a short RNA profile in 2013 and 2014 in Sukhothai and Phetchaboon provinces, Thailand. J Med Virol. 2017;89(4):615–20. doi:10.1002/jmv.24669.
  • Kondo K, Tsugawa T, Ono M, Ohara T, Fujibayashi S, Tahara Y, Kubo N, Nakata S, Higashidate Y, Fujii Y, et al. Clinical and molecular characteristics of human rotavirus G8P[8] outbreak strain, Japan, 2014. Emerg Infect Dis. 2017;23(6):968–72. doi:10.3201/eid2306.160038.
  • Leshem E, Lopman B, Glass R, Gentsch J, Bányai K, Parashar U, Patel M. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(9):847–56. doi:10.1016/S1473-3099(14)70832-1.
  • Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022–28. doi:10.1056/NEJM199610033351404.
  • Baker JM, Dahl RM, Cubilo J, Parashar UD, Lopman BA. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001–2016. BMC Infect Dis. 2019;19(1):186. doi:10.1186/s12879-019-3816-7.
  • Pitzer VE, Bilcke J, Heylen E, Crawford FW, Callens M, De Smet F, Van Ranst M, Zeller M, Matthijnssens J. Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium? Sci Rep. 2015;5(1):18585. doi:10.1038/srep18585.
  • Hallowell BD, Parashar UD, Curns A, DeGroote NP, Tate JE. Trends in the laboratory detection of rotavirus before and after implementation of routine rotavirus vaccination — United States, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019;68(24):539–43. doi:10.15585/mmwr.mm6824a2.
  • Enweronu-Laryea CC, Armah G, Sagoe KW, Ansong D, Addo-Yobo E, Diamenu SK, Mwenda JM, Parashar UD, Tate JE. Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5 years of age, ghana, 2009-2016. Vaccine. 2018;36(47):7131–34. doi:10.1016/j.vaccine.2018.02.058.
  • Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013;57(1):13–20. doi:10.1093/cid/cit164.